Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Leukemia and LPL[original query]
MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
American journal of clinical pathology 2013 Sep 140 (3): 387-94.
Ondrejka Sarah L, Lin Jeffrey J, Warden Doug W, Durkin Lisa, Cook James R, Hsi Eric
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
Leukemia research 2015 Aug 39 (8): 840-5.
Morabito Fortunato, Cutrona Giovanna, Mosca Laura, D'Anca Marianna, Matis Serena, Gentile Massimo, Vigna Ernesto, Colombo Monica, Recchia Anna Grazia, Bossio Sabrina, De Stefano Laura, Maura Francesco, Manzoni Martina, Ilariucci Fiorella, Consoli Ugo, Vincelli Iolanda, Musolino Caterina, Cortelezzi Agostino, Molica Stefano, Ferrarini Manlio, Neri Antoni
Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients.
PloS one 2015 10 (3): e0121526.
Rombout Ans, Stamatopoulos Basile, Lagneaux Laurence, Lust Sofie, Offner Fritz, Naessens Evelien, Vanderstraeten Hanne, Verhasselt Bruno, Philippé J
LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
European journal of haematology 2015 Nov .
Kristensen Louise, Kristensen Thomas, Abildgaard Niels, Royo Cristina, Frederiksen Mikael, Mourits-Andersen Torben, Campo Elias, Møller Michael B
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Leukemia & lymphoma 2016 May 1-10.
Plesingerova Hana, Librova Zuzana, Plevova Karla, Libra Antonin, Tichy Boris, Skuhrova Francova Hana, Vrbacky Filip, Smolej Lukas, Mayer Jiri, Bryja Vitezslav, Doubek Michael, Pospisilova Sar
LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia.
Annals of hematology 2020 8 99 (10): 2343-2349.
Liu Wei, Burger Jan A, Xu Jie, Tang Zhenya, Toruner Gokce, Khanlari Mahsa, Medeiros L Jeffrey, Tang Guil
EXPRESSION OF LIPOPROTEIN LIPASE AND c-MYC ONCOGENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFFECTED BY THE CHORNOBYL ACCIDENT.
Problemy radiatsiinoi medytsyny ta radiobiolohii 2020 12 25 421-429.
Bilous N I, Abramenko I V, Chumak A A, Diagil I S, Martina Z
Association of lipoprotein lipase expression with TP53 gene polymorphisms in chronic lymphocytic leukemia cells.
Experimental oncology 2021 9 43 (3): 224-228.
Abramenko I, Bilous N, Chumak A, Dyagil I, Martina
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.
Neoplasia (New York, N.Y.) 2021 3 23 (4): 361-374.
Wang Yingjun, Gali Vasantha Lakshmi, Xu-Monette Zijun Y, Sano Dahlia, Thomas Sheeba K, Weber Donna M, Zhu Feng, Fang Xiaosheng, Deng Manman, Zhang Mingzhi, Hagemeister Fredrick B, Li Yong, Orlowski Robert Z, Lee Hans Chulhee, Young Ken
TOP